274
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Racial differences in motor neuron disease

, , , &
Pages 114-118 | Received 23 May 2013, Accepted 20 Aug 2013, Published online: 25 Sep 2013

References

  • McGuire V, Longsreth WT Jr, Koepsell TD, van Belle G. Incidence of amyotrophic lateral sclerosis in three counties in western Washington State. Neurology. 1996;47:571–3.
  • Chio A, Mora G, Calvo A, Mazzini L, Bottachi E, Mutani R. Epidemiology of ALS in Italy: a 10-year prospective population based study. Neurology. 2009;72:725–31.
  • Piemonte and Valle d’Aosta Register for Amyotrophic Lateral Sclerosis (PARALS). Incidence of ALS in Italy: evidence for a uniform frequency in Western countries. Neurology. 2001;56:239–44.
  • Abhinav K, Stanton B, Johnston C, Hardstaff J, Orrell RW, Howard R, et al. Amyotrophic lateral sclerosis in south-east England: a population based study. The South East England Register for Amyotrophic Lateral Sclerosis (SEALS Registry). Neuroepidemiology. 2007;29:44–8.
  • O’Toole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, Hardiman O. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry. 2008;79:30–2.
  • Forbes RB, Colville S, Parratt J, Swingler RJ.The incidence of motor neuron disease in Scotland.J Neurol. 2007; 254:866–9.
  • Logroscino G, Traynor BJ, Hardiman O, Chiò A, Mitchell D, Swingler RJ, et al. EURALS. Incidence of amyotrophic lateral sclerosis in Europe.J Neurol Neurosurg Psychiatry. 2010;81:385–90
  • Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007; 68:1002–7.
  • Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population based mortality study. Neurology. 2009;72:1640–5.
  • Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;5:293–9.
  • Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with ALS. Drug, nutritional, and respiratory therapies (an evidence based review).Neurology. 2009;73: 1218–26.
  • Horner RD, Kamins KG, Feussner JR, Grambow SC, Hoff-Lindquist J, Harati Y, et al. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology. 2003; 61:742–9.
  • Marin B, Kacem I, Diagana M, Boulesteix M, Gouider R, Preux PM, Couratier P;Tropals Collaboration. Juvenile- and adult-onset ALS/MND among Africans: incidence, phenotype, survival. A review. Amyotroph Lateral Scler. 2012;13:276–83.
  • Kazamel M, Cutter G, Claussen G, Alsharabati M, Oh SJ, Lu L, King PH. Epidemiological features of amyotrophic lateral sclerosis in a large clinic-based African American population. Amyotroph Lateral Scler Frontotemporal Degen. Posted online on 5 Mar 2013.
  • Ref: http://www.arminorityhealth.com/pdf/AfricanAmericanHealthReport,2012.pdf.
  • Burrell JR, Vucic S, Kiernan MC. Isolated bulbar phenotype of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12:283–9.
  • Turner MR, Scaber J, Goodfellow JA, Lord ME, Marsden R, Talbot K.The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis. J Neurol Sci. 2010:294:81–5.
  • Saeed M, Yang Y, Deng HX, Hung WY, Siddique N, Dellefave L, et al. Age and founder effect of SOD1 A4V mutation causing ALS. Neurology. 2009;72:1634–9.
  • Wright Willis A, Evanoff BA, Lian M, Criswell SR, Racette BA. Geographic and ethnic variation in Parkinson's disease: a population based study of US Medicare beneficiaries. Neuroepidemiology. 2010;34:143–51.
  • Hemming JP, Gruber-Baldini AL, Anderson KE, Fishman PS, Reich SG, Weiner WJ, Shulman LM. Racial and socioeconomic disparities in Parkinsonism. Arch Neurol. 2011;68:498–503.
  • Chin A, Negash S, Hamilton R. Diversity and Disparity in Dementia: The Impact of Ethnoracial Differences in Alzheimer's Disease. Alzheimer Dis Assoc Disord. 2011; 25:187–85.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.